The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.

Hirudin, a potent 65-residue polypeptide inhibitor of alpha-thrombin found in the saliva of the leech Hirudo medicinalis, and fragments thereof are potentially useful as antithrombotic agents. Hirugen, the synthetic N-acetylated COOH-terminal dodecapeptide (Ac-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3)-Leu) of hirudin was shown in the present study to behave as a pure competitive inhibitor (Ki = 0.54 microM) of human alpha-thrombin-catalyzed release of fibrinopeptide A from human fibrinogen. In contrast to this inhibitory activity, hirugen slightly enhanced (increased kcat/Km 1.6-fold) alpha-thrombin-catalyzed hydrolysis of the fluorogenic tripeptide substrate N-p-Tosyl-Gly-Pro-Arg-7-amino-4-methylcoumarin. These observations indicate that hirugen binds to alpha-thrombin at an exosite distinct from the active site, and that interaction with this exosite is a major determinant of the competence of alpha-thrombin to bind fibrinogen. Consistent with this view, hirugen blocked binding of fibrin II to alpha-thrombin. Studies of the effect of hirugen on the rate of inactivation of alpha-thrombin by antithrombin III (AT), the major plasma inhibitor of alpha-thrombin, indicated that binding of hirugen to alpha-thrombin results in less than a 2.5-fold decrease in the rate of inactivation of alpha-thrombin by AT, both in the absence and presence of heparin. This behavior is distinct from that of active site-directed competitive inhibitors of alpha-thrombin which bind to alpha-thrombin and block both conversion of fibrinogen to fibrin and inactivation of alpha-thrombin by AT. Hirugen, an exosite-directed competitive inhibitor, blocks the interaction of alpha-thrombin with fibrinogen while leaving alpha-thrombin competent to react with AT. Thus, unlike active site-directed competitive inhibitors, hirugen should act in concert with AT and heparin to reduce the amount of fibrinogen that is processed during the lifetime of alpha-thrombin in plasma.

• Publication year

  1990

• Venue

  Journal of Biological Chemistry

• Publication date

  1990-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0021-9258(18)77372-9PMID 2380171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.

  1990cited by this paper
• Anticoagulant activity of synthetic hirudin peptides.

  1989cited by this paper
• The hirudin-binding site of human alpha-thrombin. Identification of lysyl residues which participate in the combining site of hirudin-thrombin complex.

  1989cited by this paper
• Kinetics of trypsin inhibition by its specific inhibitors.

  1989cited by this paper
• Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

  1989cited by this paper
• Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.

  1988cited by this paper
• Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.

  1988cited by this paper
• Enzymatic properties of proteolytic derivatives of human alpha-thrombin.

  1988cited by this paper
• The use of sequence-specific antibodies to identify a secondary binding site in thrombin.

  1988cited by this paper
• Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.

  1988cited by this paper
• Inhibited thrombins. Interactions with fibrinogen and fibrin.

  1987cited by this paper
• Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.

  1987cited by this paper
• Identification of regions of alpha-thrombin involved in its interaction with hirudin.

  1987cited by this paper
• Effect of heparin on the interaction between thrombin and hirudin.

  1987cited by this paper
• Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity.

  1987cited by this paper
• Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.

  1987cited by this paper
• Kinetics of the inhibition of thrombin by hirudin.

  1986cited by this paper
• Multiple complexes of thrombin and heparin.

  1986cited by this paper
• Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization.

  1986cited by this paper
• The structures and proteolytic specificities of autolysed human thrombin.

  1986cited by this paper
• Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate.

  1986cited by this paper
• The effect of bovine thrombomodulin on the specificity of bovine thrombin.

  1986cited by this paper
• Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.

  1986cited by this paper
• Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.

  1986cited by this paper
• Human alpha-thrombin binding to nonpolymerized fibrin-Sepharose: evidence for an anionic binding region.

  1985cited by this paper
• Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.

  1985cited by this paper
• Regulation of formation of factor XIIIa by its fibrin substrates.

  1985cited by this paper
• A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.

  1984cited by this paper
• Solution composition dependent variation in extinction coefficients for p-nitroaniline.

  1983cited by this paper
• Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.

  1983cited by this paper
• Studies on the mechanism of thrombin. Interaction with fibrin.

  1983cited by this paper
• p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases.

  1982cited by this paper
• Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin.

  1982cited by this paper
• Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue.

  1981cited by this paper
• Selective immobilization of alpha-thrombin by surface-bound fibrin.

  1981cited by this paper
• Slow, spontaneous dissociation of the antithrombin—thrombin complex produces a proteolytically modified form of the inhibitor

  1980cited by this paper
• The binding of thrombin by fibrin.

  1979cited by this paper
• The kinetics of formation and dissociation of the bovine thrombin.antithrombin III complex.

  1979cited by this paper
• Affinity of fibronectin to collagens of different genetic types and to fibrinogen

  1978cited by this paper
• Human thrombins. Production, evaluation, and properties of alpha-thrombin.

  1977cited by this paper
• The size and shape of human and bovine antithrombin III.

  1977cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper

• Exosite crosstalk in thrombin.

  2025cites this paper
• Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease

  2023cites this paper
• Effect of Sulfotyrosine and Negatively Charged Amino Acid of Leech‐Derived Peptides on Binding and Inhibitory Activity Against Thrombin

  2023cites this paper
• Prospection of Peptide Inhibitors of Thrombin from Diverse Origins Using a Machine Learning Pipeline

  2023cites this paper
• Thrombin: An Approach to Developing a Higher-Order Reference Material and Reference Measurement Procedure for Substance Identity, Amount, and Biological Activities

  2020cites this paper
• Inhibits Factor Va-Accelerated Prothrombin Activation

  2018cites this paper
• Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

  2017cites this paper
• Evolution of salivary secretions in haematophagous animals

  2017cites this paper
• Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function

  2016cites this paper
• Synthetic, Sulfated, Lignin-Based Anticoagulants

  2014cites this paper
• Thrombin Inhibitors fromDifferent Animals

  2014cites this paper
• Investigation of thrombin activity with PAR 1-based fluorogenic peptides.

  2013cites this paper
• Effect of O-glycosylation and tyrosine sulfation of leech-derived peptides on binding and inhibitory activity against thrombin.

  2012cites this paper
• Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.

  2012cites this paper
• Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications.

  2010cites this paper
• Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)

  2010cites this paper
• Thrombin Inhibitors from Different Animals

  2010cites this paper
• Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets

  2010cites this paper
• HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions

  2009cites this paper
• Noncompetitive Inhibitor of Thrombin

  2009cites this paper
• Long Range Communication between Exosites 1 and 2 Modulates Thrombin Function*

  2009cites this paper
• SYNTHESIS AND BIOCHEMICAL STUDIES ON SULFATED MONOMERS OF LOW MOLECULAR WEIGHT LIGNINS

  2009cites this paper
• Structural Insights into the Life History of Thrombin

  2008cites this paper
• Inhibition of thrombin activity by prothrombin activation fragment 1.2

  2007cites this paper
• Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick*

  2007cites this paper
• Directed evolution of a beta -sheet scaffold for targeting proteins involved in human disease -- Thrombin and the vascular endothelial growth factor (VEGF)

  2007cites this paper
• Ecotin modulates thrombin activity through exosite-2 interactions.

  2006cites this paper
• Boophilus microplus: its saliva contains microphilin, a small thrombin inhibitor.

  2006cites this paper
• Novel Fluorescent Prothrombin Analogs as Probes of Staphylocoagulase-Prothrombin Interactions*

  2006cites this paper
• Proteins in the saliva of the Ixodida (ticks): pharmacological features and biological significance.

  2006cites this paper
• Chromogenic substrates as fundamental tool to design new thrombin inhibitors

  2005cites this paper
• Molecular aptamers for real-time protein-protein interaction study.

  2005cites this paper
• PURIFICAÇÃO E CARACTERIZAÇÃO DA MICROFILINA, O SEGUNDO INIBIDOR DE TROMBINA DA SALIVA DO CARRAPATO Boophilus microplus

  2005cites this paper
• Targeting exosites on blood coagulation proteases.

  2005cites this paper
• Novel antithrombotic strategies for the treatment of coronary artery thrombosis: A critical appraisal

  2005cites this paper
• Exosite-interactive Regions in the A1 and A2 Domains of Factor VIII Facilitate Thrombin-catalyzed Cleavage of Heavy Chain*

  2005cites this paper
• Current Perspectives Direct Thrombin Inhibitors in Cardiovascular Medicine

  2005cites this paper
• The anticoagulant fraction from the leaves ofDiospyros kaki L. has an antithrombotic activity

  2005cites this paper
• Protein-protein interaction studies based on molecular aptamers by affinity capillary electrophoresis.

  2004cites this paper
• Thrombin Domains: Structure, Function and Interaction with Platelet Receptors

  2004cites this paper
• Modes and consequences of thrombin's interaction with fibrin.

  2004cites this paper
• Suramin interaction with human α-thrombin: inhibitory effects and binding studies

  2004cites this paper
• Hirudin (desulfated, 54-65) contracts canine coronary arteries: extracellular calcium influx mediates hirudin-induced contractions.

  2004cites this paper
• Characterization of Bothrops jararaca coagulation inhibitor (BjI) and presence of similar protein in plasma of other animals.

  2004cites this paper
• Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.

  2004cites this paper
• Activation of factor VIII and mechanisms of cofactor action.

  2004cites this paper
• Effects of Activation Peptide Bond Cleavage and Fragment 2 Interactions on the Pathway of Exosite I Expression during Activation of Human Prethrombin 1 to Thrombin*

  2003cites this paper
• Effects of Anticoagulant from Spirodela polyrhiza in Rats

  2003cites this paper
• Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis.

  2003cites this paper
• a-Thrombin within Fibrin Clots : Inactivation of Thrombin by Antithrombin-Ill

  2003cites this paper
• Thrombin domains: structure, function and interaction with platelet receptors.

  2003cites this paper
• Bothrojaracin, a Proexosite I Ligand, Inhibits Factor Va-Accelerated Prothrombin Activation

  2002cites this paper
• Binding of Exosite Ligands to Human Thrombin

  2002cites this paper
• Thrombostasin: purification, molecular cloning and expression of a novel anti-thrombin protein from horn fly saliva.

  2002cites this paper
• Anticoagulant from Taraxacum platycarpum

  2002cites this paper
• Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin.

  2002cites this paper
• Fibrinolytic and Antithrombotic Protease from Spirodela polyrhiza

  2001cites this paper
• Characterization of bothrojaracin interaction with human prothrombin

  2001cites this paper
• The Amino Acid Sequence in Fibrin Responsible for High Affinity Thrombin Binding

  2001cites this paper
• The TF:VIIa Complex: Clinical Significance, Structure-function Relationships and Its Role in Signaling and Metastasis

  2001cites this paper
• Isothermal titration calorimetry in drug discovery.

  2001cites this paper
• Acceleration of Ca2+ ionophore-induced arachidonic acid liberation by thrombin without the proteolytic action toward the receptor in human platelets.

  2001cites this paper
• Structural features of a snake venom thrombin-like enzyme: thrombin and trypsin on a single catalytic platform?

  2001cites this paper
• A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.

  2001cites this paper
• Polymorphism of the thrombostasin gene in the horn fly (Haematobia irritans) revealed in a cDNA library and in genomic DNA

  2001cites this paper
• Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin*

  2001cites this paper
• Fibrinolytic and antithrombotic protease from Ganoderma lucidum

  2000cites this paper
• Inhibitors of Thrombin and Factor Xa

  2000cites this paper
• Peptide exosite inhibitors of factor VIIa as anticoagulants

  2000cites this paper
• Characterization of Proexosite I on Prothrombin*

  2000cites this paper
• Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release*

  2000cites this paper
• Enzymology: Not just an active site

  2000cites this paper
• Fibrinolytic serine protease from spirodela polyruiza

  1999cites this paper
• Thrombin Receptor Occupancy Modulates Aggregation Efficiency and Platelet Surface Expression of vWF and Thrombospondin at Low Thrombin Concentrations

  1999cites this paper
• Systematic study of the substituted active C-terminus of hirudin.

  1999cites this paper
• Allosteric modulation of BPTI interaction with human alpha- and zeta-thrombin.

  1999cites this paper
• Management of Acute Coronary Syndromes

  1999cites this paper
• Thrombin Interacts with Thrombomodulin, Protein C, and Thrombin-activatable Fibrinolysis Inhibitor via Specific and Distinct Domains*

  1999cites this paper
• Anophelin: kinetics and mechanism of thrombin inhibition.

  1999cites this paper
• Role of Regulatory Exosite I in Binding of Thrombin to Human Factor V, Factor Va, Factor Va Subunits, and Activation Fragments*

  1999cites this paper
• From natural to synthetic multisite thrombin inhibitors.

  1999cites this paper
• Inhibition of Thrombin-catalyzed Factor V Activation by Bothrojaracin

  1998cites this paper
• Allosteric effects of a monoclonal antibody against thrombin exosite II.

  1998cites this paper
• Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis.

  1998cites this paper
• Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus.

  1998cites this paper
• Allosteric modulation of the activity of thrombin.

  1997cites this paper
• Modulation of Thrombin and Heparin Activities by Fibrin

  1997cites this paper
• Inactivation of Thrombin by Antithrombin Is Accompanied by Inactivation of Regulatory Exosite I*

  1997cites this paper
• Identification of glycyrrhizin as a thrombin inhibitor.

  1997cites this paper
• Production of a recombinant antithrombotic and fibrinolytic protein, PLATSAK, in Escherichia coli.

  1997cites this paper
• Kinetic Pathway for the Slow to Fast Transition of Thrombin

  1997cites this paper
• The Ability of Thrombin Inhibitors to Reduce the Thrombin Activity Generated in Plasma on Extrinsic and Intrinsic Activation

  1997cites this paper
• Evidence for Allosteric Linkage between Exosites 1 and 2 of Thrombin*

  1997cites this paper
• Molecular basis for the resistance of fibrin-bound thrombin to inactivation by heparin/serpin complexes.

  1997cites this paper
• Thrombin affinity mapping of its receptor tethered ligand.

  1997cites this paper
• Heparin enhances the catalytic activity of des-ETW-thrombin.

  1996cites this paper
• Involvement of Thrombin Anion-binding Exosites 1 and 2 in the Activation of Factor V and Factor VIII*

  1996cites this paper
• Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen*

  1996cites this paper
• Anticoagulant repertoire of the hookworm Ancylostoma caninum.

  1996cites this paper
• Biochemistry and biology of hirudin.

  1996cites this paper